Biophan Reaches Major Milestone in Intellectual Property
Expands Biomedical Technology Portfolio to Total of 80 Patents, Licenses or Applications
The Company has expanded its advanced technology portfolio 30% in the last 3 months alone, and the steep rate of technology acquisition is continuing. Biophan's patents and licenses involve several cutting-edge fields of research and development, including nanotechnology and biothermal battery technology.
"The future and success of Biophan lies in the commercialization of critically important and far-reaching science and technology. Biophan is at the forefront of this development," said Mr. Weiner. "It is extraordinary that we have been able to amass so much cutting-edge technology in such a short time, and we are excited by the vast market opportunities available for the products we're developing with this world-class portfolio of intellectual property." Our technology has the potential to impact millions of lives as biomedical devices are made safe for use with MRI, or are powered by biothermal batteries, or enhanced by drug delivery innovations.
Biophan recently announced a joint development agreement with the NASA Ames Research Center for Nanotechnology, Moffet Field, CA, for the characterization and development of high-density, nano-engineered thermoelectric materials for use with implantable medical devices.
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.